Trial intelligence / Profile preview

Geodon as adjunctive therapy in Bipolar I Depression

NCT00483548Phase 3Completed

Sponsor
Viatris
Start
Oct 2007
Primary completion
Dec 2008
Modality
Small Molecules
Countries
3
01

Overview

A Phase 3 trial of ziprasidone in bipolar I disorder, sponsored by Viatris. Started Oct 2007; status: completed.

02

Drugs

ziprasidone
03

Conditions

bipolar I disorder

Beyond the preview

Go deeper on NCT00483548.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00483548.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call